mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.8 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
AMG-706 |
GDSC1000 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
Irinotecan |
FIMM |
pan-cancer |
AAC |
0.036 |
0.8 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.0088 |
0.8 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
BIBW2992 |
FIMM |
pan-cancer |
AAC |
-0.048 |
0.8 |